ViewRay Secures $30,000,000 New Financing

  • Feed Type
  • Date
    12/17/2013
  • Company Name
    ViewRay
  • Mailing Address
    2 Thermo Fisher Way Oakwood Village, OH 44146
  • Company Description
    The patent pending Renaissance race System 1000 combines two proven technologies: magnetic resonance imaging (MRI) and gamma ray radiotherapy. Conversely, today’s competing image-guided radiotherapy systems are based on linear accelerators which require CT or X-Ray scanners to capture patient images—linacs cannot work with MRI because of technical incompatibilities between the two devices.
  • Website
    http://www.viewray.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The funds are intended to support the worldwide commercialization of the ViewRay system, which has already been acquired by five leading cancer treatment centers worldwide.
  • M&A Terms
  • Venture Investor
    Aisling Capital
  • Venture Investor
    Fidelity BioSciences
  • Venture Investor
    Kearny Venture Partners
  • Venture Investor
    OrbiMed Advisors
  • Venture Investor
    Hercules Technology Growth Capital

By posting a comment, you agree to our terms and conditions.